Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $1.53 by 3.27 percent. This is a 15.51 percent decrease over earnings of $1.87 per share from the same period last year.
Protolabs Q1 Earnings Beat Estimates, Boasts Solid Growth Of Digital Networks
Proto Labs, Inc. (NYSE:PRLB) reported a first-quarter FY23 revenue of $125.86 million, an increase of 1.4% year-over-year. Revenues beat the…